Metagenomi Therapeutics (MGX) Receivables (2023 - 2025)
Metagenomi Therapeutics (MGX) reported Receivables of $305000.0 for Q4 2025, down 72.27% year-over-year from $1.1 million in Q4 2024, and down 66.11% quarter-over-quarter from $900000.0 in Q2 2025.
Metagenomi Therapeutics (MGX) Receivables (2023 - 2025) Analysis & Trends
Metagenomi Therapeutics (MGX) has 3 years of Receivables data on file, last reported at $305000.0 in Q4 2025.
- Receivables for Q4 2025 came in at $305000.0, down 72.27% year-over-year; the trailing twelve-month figure through Dec 2025 was $305000.0 (down 72.27% YoY), and the FY2025 annual result was $305000.0, down 72.27% from the prior year.
- Receivables fell to $305000.0 in Q4 2025 per MGX's latest filing, from $900000.0 in the prior quarter.
- Over five years, Receivables peaked at $2.1 million in Q1 2024 and troughed at $100000.0 in Q3 2024.
- A 3-year average of $1.1 million and a median of $1.0 million in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables sank 45.0% in 2024, then slumped 72.27% in 2025.
- A 3-year view of Receivables shows it stood at $2.0 million in 2023, then sank by 45.0% to $1.1 million in 2024, then tumbled by 72.27% to $305000.0 in 2025.
- Business Quant data shows MGX's Receivables at $305000.0 in Q4 2025, $900000.0 in Q2 2025, and $900000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 305,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 2.00 Mn |